Gensenta

Gensenta, established in 1923, is a prominent pharmaceutical company operating as a subsidiary of Eczacıbaşı. Specializing in drug production and the manufacturing of active pharmaceutical ingredients (APIs), Gensenta is dedicated to advancing global health through rigorous scientific innovation. The company's commitment extends to robust research and development initiatives, alongside a strong focus on sustainability and corporate responsibility, positioning it as a key player in the healthcare sector. Its operations are geared towards serving healthcare professionals and organizations worldwide with high-quality pharmaceutical solutions.

With an employee range of 500 - 1,000 individuals, Gensenta leverages its expertise to develop and produce essential pharmaceutical components. The company's dedication to quality and innovation is supported by its team, and you can Meet Gensenta's team to understand the driving force behind their advancements. Gensenta's strategic focus on R&D ensures it remains at the forefront of pharmaceutical science, contributing significantly to medical progress and patient well-being.

Gensenta aims to serve international markets, delivering critical pharmaceutical ingredients and finished products. The company generates an annual revenue of $66.0M, underscoring its substantial market presence and operational capacity. By adhering to stringent quality standards and fostering a culture of continuous improvement, Gensenta reinforces its role in the global pharmaceutical supply chain, providing reliable and innovative healthcare solutions.